Cargando…
Pragmatic Trials for Noncommunicable Diseases: Relieving Constraints
In this month's editorial, PLOS Medicine Editorial Board member Anushka Patel and Ruth Webster discuss how applying rules for drug efficacy trials can impede pragmatic trials of interventions for noncommunicable diseases.
Autores principales: | Patel, Anushka, Webster, Ruth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4811534/ https://www.ncbi.nlm.nih.gov/pubmed/27022969 http://dx.doi.org/10.1371/journal.pmed.1001986 |
Ejemplares similares
-
Nutrition, Microbiota and Noncommunicable Diseases
por: Plaza-Diaz, Julio
Publicado: (2020) -
Noncommunicable Diseases: A Globalization of Disparity?
por: Hotez, Peter J., et al.
Publicado: (2015) -
Noncommunicable diseases: a call for papers
por: Tangcharoensathien, Viroj, et al.
Publicado: (2018) -
Chronic noncommunicable diseases and population surveys
por: de Castilho, Euclides Ayres, et al.
Publicado: (2017) -
Preventing and controlling noncommunicable diseases in the Caribbean
Publicado: (2018)